The Russian Federation’s Ministry of Defense has announced the start of the coronavirus vaccine clinical trials, which 50 militaries had joined as the volunteers. This was reported by Russian Interfax.
The “48th Central Research Institute of the Ministry of Defense of the Russian Federation” employees took part in the Russian vaccine development. The tests will be held based on this institute.
In particular, the “National Research Center for Epidemiology and Microbiology after M.F. Gamalia”, the Russian Federation’s Ministry of Health tested a vector vaccine against COVID-19 on its employees unofficially. After that, the Center’s director, the Academician of the Russian Academy of Sciences Alexander Ginzburg said that the experiment had been successful. He noted that there had been no negative effects from the vaccination, and the participants received the immunity against the virus.
On June 3, the first group of volunteers is to be settled in a special medical institution based on the institute for a preliminary in-depth medical examination and preparation for the experiment.
“50 militaries, including five women who voluntarily had expressed a desire to participate in the testing of a modern drug, were selected for the vaccine’s safety and effectiveness testing”, the statement said.
The Russian Ministry of Defense explained that this was a vector vaccine being based on adenovirus DNA, in which the SARS-CoV-2 coronavirus gene had been incorporated. Adenovirus is to be used as a “container” to deliver the coronavirus gene to cells, start the synthesis of the new coronavirus shell’s proteins and thus “introduce” the potential enemy to an immune system.
In turn, Defense Minister Sergei Shoigu promised President Vladimir Putin that the military would complete clinical trials of the vaccine by the end of July.